179 related articles for article (PubMed ID: 36293302)
1. MicroRNA-19b Plays a Key Role in 5-Fluorouracil Resistance and Predicts Tumor Progression in Locally Advanced Rectal Cancer Patients.
Santos A; Cristóbal I; Rubio J; Caramés C; Luque M; Sanz-Álvarez M; Zazo S; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293302
[TBL] [Abstract][Full Text] [Related]
2. Low MicroRNA-19b Expression Shows a Promising Clinical Impact in Locally Advanced Rectal Cancer.
Rubio J; Cristóbal I; Santos A; Caramés C; Luque M; Sanz-Alvarez M; Zazo S; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33810186
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of the miR-19b/PPP2R5E Signaling Axis Shows High Functional Impact in Colorectal Cancer Cells.
Santos A; Cristóbal I; Caramés C; Luque M; Sanz-Álvarez M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175484
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
Cristóbal I; Rubio J; Santos A; Torrejón B; Caramés C; Imedio L; Mariblanca S; Luque M; Sanz-Alvarez M; Zazo S; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32580513
[TBL] [Abstract][Full Text] [Related]
5. Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients.
Cristóbal I; Santos A; Rubio J; Caramés C; Zazo S; Sanz-Álvarez M; Luque M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638487
[TBL] [Abstract][Full Text] [Related]
6. Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells.
Kurokawa K; Tanahashi T; Iima T; Yamamoto Y; Akaike Y; Nishida K; Masuda K; Kuwano Y; Murakami Y; Fukushima M; Rokutan K
J Gastroenterol; 2012 Aug; 47(8):883-95. PubMed ID: 22382630
[TBL] [Abstract][Full Text] [Related]
7. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
[TBL] [Abstract][Full Text] [Related]
8. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.
Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J
Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.
Caramés C; Cristobal I; Moreno V; Marín JP; González-Alonso P; Torrejón B; Minguez P; Leon A; Martín JI; Hernández R; Pedregal M; Martín MJ; Cortés D; García-Olmo D; Fernández MJ; Rojo F; García-Foncillas J
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271609
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Svoboda M; Sana J; Fabian P; Kocakova I; Gombosova J; Nekvindova J; Radova L; Vyzula R; Slaby O
Radiat Oncol; 2012 Nov; 7():195. PubMed ID: 23167930
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-199b Deregulation Shows Oncogenic Properties and Promising Clinical Value as Circulating Marker in Locally Advanced Rectal Cancer Patients.
Santos A; Cristóbal I; Rubio J; Caramés C; Luque M; Sanz-Alvarez M; Morales-Gallego M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216319
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.
Caramés C; Cristóbal I; Moreno V; del Puerto L; Moreno I; Rodriguez M; Marín JP; Correa AV; Hernández R; Zenzola V; Hernández T; León A; Martín JI; Sánchez-Fayos P; García-Olmo D; Rojo F; Goel A; Fernandez-Aceñero MJ; García-Foncillas J
Int J Colorectal Dis; 2015 Jul; 30(7):899-906. PubMed ID: 25953218
[TBL] [Abstract][Full Text] [Related]
13. Capecitabine versus 5-fluorouracil in neoadjuvant chemoradiotherapy of locally advanced rectal cancer: A meta-analysis.
Zhu J; Zeng W; Ge L; Yang X; Wang Q; Wang H
Medicine (Baltimore); 2019 Apr; 98(17):e15241. PubMed ID: 31027072
[TBL] [Abstract][Full Text] [Related]
14. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.
An X; Lin X; Wang FH; Goodman K; Cai PQ; Kong LH; Fang YJ; Gao YH; Lin JZ; Wan DS; Pan ZZ; Ding PR
Eur J Cancer; 2013 Mar; 49(4):843-51. PubMed ID: 23063351
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.
Borg C; Mantion G; Boudghène F; Mornex F; Ghiringhelli F; Adenis A; Azria D; Balosso J; Ben Abdelghani M; Bachet JB; Vendrely V; François Y; Conroy T; Rio E; Roullet B; Spaëth D; Quero L; Lakkis Z; Coudert M; Ionescu-Goga M; Tanang A; André T
Clin Colorectal Cancer; 2019 Sep; 18(3):200-208.e1. PubMed ID: 31311761
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
17. Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study.
Borg C; André T; Mantion G; Boudghène F; Mornex F; Maingon P; Adenis A; Azria D; Piutti M; Morsli O; Bosset JF
Ann Oncol; 2014 Nov; 25(11):2205-2210. PubMed ID: 25122693
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
[TBL] [Abstract][Full Text] [Related]
19. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.
Sclafani F; Brown G; Cunningham D; Rao S; Tekkis P; Tait D; Morano F; Baratelli C; Kalaitzaki E; Rasheed S; Watkins D; Starling N; Wotherspoon A; Chau I
Oncologist; 2017 Jun; 22(6):728-736. PubMed ID: 28476941
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.
Shang J; Yang F; Wang Y; Wang Y; Xue G; Mei Q; Wang F; Sun S
J Cell Biochem; 2014 Apr; 115(4):772-84. PubMed ID: 24249161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
